Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
XENON XE 129 hyperpolarized in Idiopathic Pulmonary Fibrosis: NCT04677426 Clinical Landscape Report 2026
16 October 2026
NCT04677426 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Colecalciferol in Anemia, Sickle Cell: NCT04662476 Clinical Landscape Report 2026
16 October 2026
NCT04662476 clinical landscape for Anemia, Sickle Cell: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Crizanlizumab-TMCA in Vaso-occlusive crisis: NCT04662931 Clinical Landscape Report 2026
16 October 2026
NCT04662931 clinical landscape for Vaso-occlusive crisis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Idebenone in Metabolic Dysfunction Associated Steatohepatitis: NCT04669158 Clinical Landscape Report 2026
16 October 2026
NCT04669158 clinical landscape for Metabolic Dysfunction Associated Steatohepatitis: endpoints, sponsor, phase, geography, readouts, asset context and develo…
9 min read
Rondaptivon Pegol in Von Willebrand Diseases: NCT04677803 Clinical Landscape Report 2026
16 October 2026
NCT04677803 clinical landscape for Von Willebrand Diseases: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
ASC-618 in Hemophilia A: NCT04676048 Clinical Landscape Report 2026
16 October 2026
NCT04676048 clinical landscape for Hemophilia A: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
LPCN-1144 in Metabolic Dysfunction Associated Steatohepatitis: NCT04685993 Clinical Landscape Report 2026
16 October 2026
NCT04685993 clinical landscape for Metabolic Dysfunction Associated Steatohepatitis: endpoints, sponsor, phase, geography, readouts, asset context and develo…
9 min read
Atorvastatin Calcium in Metabolic Dysfunction Associated Steatohepatitis: NCT04679376 Clinical Landscape Report 2026
16 October 2026
NCT04679376 clinical landscape for Metabolic Dysfunction Associated Steatohepatitis: endpoints, sponsor, phase, geography, readouts, asset context and develo…
9 min read
L-Glutamine in Hemoglobin SC Disease: NCT04684381 Clinical Landscape Report 2026
16 October 2026
NCT04684381 clinical landscape for Hemoglobin SC Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Valoctocogene roxaparvovec in Hemophilia A: NCT04684940 Clinical Landscape Report 2026
16 October 2026
NCT04684940 clinical landscape for Hemophilia A: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Namodenoson in Metabolic Dysfunction Associated Steatohepatitis: NCT04697810 Clinical Landscape Report 2026
16 October 2026
NCT04697810 clinical landscape for Metabolic Dysfunction Associated Steatohepatitis: endpoints, sponsor, phase, geography, readouts, asset context and develo…
9 min read
Foscenvivint in Hemophilia: NCT04688034 Clinical Landscape Report 2026
16 October 2026
NCT04688034 clinical landscape for Hemophilia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.